What is the epitalon dosage?

Draw to

unitsmL

0.3 mL · 30 units syringe0.5 mL · 50 units syringe1 mL · 100 units syringe3 mL · 3cc syringe0.5 mL · 20 units, U-40 syringe1 mL · 40 units, U-40 syringe

051015202530 01020304050 0102030405060708090100 00.511.522.53 05101520 010203040

    mL
    Syringe scale
    Syringe

    Concentration is the powder in the vial divided by the water. The draw is the dose divided by the concentration, in mL, times 100 on a U-100 syringe or 40 on a U-40. Every figure comes from what you enter.

    Save to Milligram
    How often

    Open in Milligram shows once the calculator has a result.

    Open in Milligram is off while the dose is more than the whole vial. Check the dose and its unit.

    Open in Milligram is off while the draw is under one unit. Check the dose and its unit.

    Open in Milligram adds Epithalon and this dose to a plan in the app, with the schedule you pick here. The vial and water are not saved.

    No epitalon label sets a dose; a review lists 0.01 mg a day intramuscularly for 10 days (Korkushko, 2007; 15 on epitalon), 0.5 mg a day sublingually for 20 days (Ivko, 2020/2021; 20 women on AEDG) and 5.0 µg per eye once daily by the parabulbar route for 10 days (Khavinson, 2002; 162 patients), while some websites cited by FDA give 5 mg to 10 mg per day.12

    The guide's example

    500 mcg of Epithalon from a 10 mg vial mixed with 4 mL is 20 units on a U-100 syringe.

    Every vial at a glance. Pick a cell to draw it on the syringe.

    Concentration is the vial's amount over its water; units are the dose over the concentration, times 100, on a U-100 syringe.
    Vial4 mL of water8 mL of water
    10 mg2.5 mg/mL: 500 mcg is 20 units1.25 mg/mL: 500 mcg is 40 units
    20 mg5 mg/mL: 500 mcg is 10 units2.5 mg/mL: 500 mcg is 20 units

    Jump to a vial 10 mg 20 mg

    Epitalon vials, mixing and syringe units

    FDA reports that websites list epitalon vials of 10, 20, 25 and 50 mg, several of them saying the product is for research use only, and that the products proposed in the nominations are 10 mg/mL and 3000 mcg/mL for subcutaneous injection.2 No diluent or water volume is stated in FDA's briefing or the two reviews. FDA adds that reliable water solubility data for epitalon free base are limited, and that because of its limited solubility in water a 3 mg/mL injection made with water may not be possible.2 The table's 20 mg in 4 mL cell comes to 5 mg/mL, above that 3 mg/mL figure from FDA.2

    500 mcg of Epithalon from a 10 mg vial mixed with 4 mL is 20 units on a U-100 syringe.

    The calculator is at the top of the page

    The 4 mL of water in this example is not taken from any source, and 500 mcg is the 0.5 mg a day the review lists for sublingual use, not an injected dose; it is shown only to work the arithmetic.1

    For other volumes, see the epitalon calculator, the mixing guide and the KLOW mixing guide.

    Doses and schedules reported for epitalon

    A narrative review says the human studies used substantially different intramuscular, sublingual and parabulbar regimens, and that this heterogeneity limits direct comparison across studies and bars reliable determination of an optimal human dosing regimen.1

    StudyDose and schedulePeopleLength
    Korkushko et al. (2007), elderly adults0.01 mg a day, intramuscular115 on epitalon, 15 on epithalamin, 10 on placebo110 days1
    Ivko et al. (2020/2021), female doctors and nurses, mainly night-shift workers0.5 mg a day, sublingual, 3 sprays twice daily1275 women aged 40–50: 20 on AEDG, 20 on placebo, 35 as reference120 days1
    Khavinson et al. (2002), congenital retinitis pigmentosa5.0 µg per eye once daily, parabulbar injection1162 patients (324 eyes) aged 18–72; control 46 patients on conventional therapy110 days1

    FDA's briefing notes that the published summary of the Korkushko et al. 2007 study it found gave no route, dosing, duration or number of subjects; the full paper was not reached in these searches.2

    Some websites cited by FDA give 5 mg to 10 mg per day by subcutaneous injection or oral supplement, and one site gives a cycle of every 4 months; FDA reports these as website statements, not label or trial doses.2 The review identified no adequate human dose-escalation or pharmacokinetic study.1 Beyond the courses in the table, the searches found no cycle length or repeat interval from a label or human trial. Apart from parabulbar injection in the retinitis pigmentosa study, the sources name no injection site, and no label states a route or site.1 More on the studies is on the epithalon page, and the group is in healing peptides; mixing and dosing of other peptides are in BPC-157 dosage and BPC-157 and TB-500.

    Epitalon storage before and after mixing

    FDA's briefing reports that lyophilized epitalon free base is recommended to be stored desiccated below -18°C, and that once reconstituted the solution is expected to be stable for 2-7 days stored at 4°C and below -18°C for future use.2 For epitalon acetate, a nominator's certificate of analysis gives sealed storage at 2°C to 8°C, and FDA reports stability up to three years at -20°C and one year in solvent at -80°C.2 These figures rest on literature and a nominator's certificate, not a label, and the searches reached no stability study of a mixed solution.

    Frequently asked questions

    Is epitalon taken at a particular time of day?

    FDA's briefing and the two reviews give no time of day or before-bed timing.

    Is there a pharmacy or label mixing instruction for epitalon?

    FDA's briefing says a Google search found no pharmacies that compound epitalon, and these searches reached no pharmacy or label mixing instruction.2

    Is epitalon FDA approved?

    A review says that at the time of writing epitalon is not an FDA-approved treatment for insomnia, longevity or any other indication.1 FDA's briefing adds that there are no approved products containing epitalon in Canada, Australia, the United Kingdom and several European countries, and none authorized by the European Medicines Agency.2

    References

    1. MDPI. Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence. 2026. pmc.ncbi.nlm.nih.gov
    2. FDA. FDA Briefing Document. fda.gov